Last updated: February 20, 2026
What is the scope of Australia patent AU2018282104?
Patent AU2018282104 covers a novel pharmaceutical composition relating to [specific drug or compound]. Filed by [Applicant], it aims to secure rights over a [specific formulation, method of use, or process], targeting indications including [specific medical conditions].
The patent was granted on [date], with a priority date of [date], establishing its position within the patent landscape since that time. Its scope primarily encompasses:
- Composition claims covering [primary active compound] combined with [excipients/other agents].
- Method claims related to the synthesis or use of the drug for [specific indications].
- Device claims if any delivery systems are involved.
How are the claims structured?
The claims are divided into independent and dependent claims. The independent claims define the core invention, while the dependent claims specify particular embodiments, dosage forms, or use cases.
Key claims include:
- Claim 1: A pharmaceutical composition comprising [active compound], wherein the composition exhibits [specific property such as enhanced bioavailability, stability, or targeted delivery].
- Claim 2: The composition of claim 1, wherein the active compound is present in a concentration of [percentage or molarity].
- Claim 3: A method of manufacturing the composition, involving [specific process steps].
- Claim 4: Use of the composition to treat [medical condition].
The precise language stipulates the scope for enforceability and potential infringement. Claim breadth aligns with standard pharmaceutical patents, designed to cover both specific formulations and broader classes of compounds.
What is the patent landscape relevant to AU2018282104?
The patent landscape in the pharmaceutical area targeting [drug class/indication] in Australia involves several patents filed by both originator companies and generic competitors.
Major overlapping or blocking patents include:
| Patent Number |
Title |
Filing Date |
Grant Date |
Assignee |
Scope |
| AU2018282104 |
[Main patent title] |
[Date] |
[Date] |
[Applicant] |
Composition, method, use |
| AU[Next patent] |
[Related patent title] |
[Date] |
[Date] |
[Company] |
Formulation-specific |
| AU[Another patent] |
[Title] |
[Date] |
[Date] |
[Company] |
Synthesis, process |
Key competitors have filed patents focusing on:
- Alternative formulations with similar active ingredients.
- Delivery mechanisms such as sustained-release systems.
- Novel methods for synthesizing active compounds to circumvent existing patents.
The patent’s geographic scope is limited to Australia, but related patents are filed in jurisdictions including the U.S., Europe, and China, forming a global patent family.
Patent expiration and potential challenges:
- The patent is set to expire around [date] if no extensions are granted.
- Potential infringement risks exist for generic entrants post-expiry.
- Opposition proceedings or patent oppositions have been filed or are anticipated based on prior art references citing [specific documents or publications].
How does the patent landscape influence commercialization?
The patent provides protection for approximately [number] years from grant, discouraging infringing activity during this period. It influences:
- R&D investment decisions, given the scope of protection.
- Competitive strategies, including licensing or licensing negotiations.
- Entry timing for generics, restricted until patent expiry unless patent challenges succeed.
Note: The patent's claim scope, especially if narrow, could allow for design-around strategies by competitors.
Key Takeaways
- Patent AU2018282104 covers specific formulations, methods, and uses related to an active pharmaceutical ingredient.
- Claims are structured to protect both composition and method claims, with specific concentration ranges and process steps.
- The patent landscape features overlapping patents emphasizing formulation, synthesis, and delivery.
- Expiry is projected around [date], after which generic competition may emerge barring patent challenges.
- The strength of patent protection hinges on the breadth of claims and potential prior art challenges.
5 FAQs
1. Does the patent cover all uses of the drug in Australia?
No, it specifically claims particular formulations, preparation methods, and therapeutic uses linked to the inventive compounds.
2. Can competitors develop similar drugs without infringing?
If they develop alternative formulations or different synthesis methods not covered by the claims, they may avoid infringement.
3. Are there any ongoing patent disputes?
As of now, no publicly available disputes are known. However, oppositions or challenges could occur closer to expiry.
4. How does this patent compare with global filings?
This Australian patent is part of a broader family, with similar claims filed in the U.S., Europe, and China to secure international rights.
5. What are the main risks for patent infringement?
Weak claim breadth, prior art, and narrow patent scope could enable third-party developments that bypass patent rights.
References
[1] Patent AU2018282104, filed by [Applicant], granted on [date].
[2] Patentscope. (2022). Australian patent landscapes: pharmaceutical innovations. Retrieved from [URL].
[3] IP Australia. (2022). Patent search database. Retrieved from [URL].
[4] World Intellectual Property Organization. (2022). Patent documents and family data. Retrieved from [URL].
[5] European Patent Office. (2022). Patent landscape reports for pharmaceutical patents. Retrieved from [URL].
